Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of patients and offering new hope for those with the life-threatening condition.

Semaglutide, the active ingredient in Ozempic, has soared in popularity recently, and shortages have made it harder for many people to get.

Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.

In addition to insurance type and employment industry, they found that semaglutide initiation was substantially higher among Americans who lived in the northeast region, as well as those who were ...

Semaglutide is the active ingredient in the weight loss medication Wegovy and the diabetes drugs Ozempic and Rybelsus, which are sometimes taken off-label for weight loss.

Learn about cost and Wegovy, financial and insurance assistance, ways to lower long-term costs, and more.

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity or overweight.

Recent research found that people taking semaglutide—the active ingredient in Ozempic and Wegovy—had more hair loss than people on other weight loss drugs. The rapid weight loss caused by ...

Semaglutide lowered the risk of dying from all causes of death, causing the researchers to believe there may be more undiscovered conditions the drug can treat.

Semaglutide is growing in popularity thanks to social media buzz, but the phenomenon is backed by real stories: many people report significant weight loss with these injectable medicines.